Riik: Iisrael
keel: inglise
Allikas: Ministry of Health
POLYETHYLENE GLYCOL 3350
NEOPHARM CONSUMER PRODUCTS LTD, ISRAEL
A06AD15
POWDER FOR ORAL SOLUTION
POLYETHYLENE GLYCOL 3350 99.365 %W/W
PER OS
Not required
BEN SHIMON FLORIS LTD, ISRAEL
MACROGOL
Treatment of constipation.
2015-10-31
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 This medicine is dispensed without a doctor’s prescription PEGLAX NEUTRAL Powder for preparing an oral solution THE ACTIVE INGREDIENT AND ITS CONCENTRATION: Polyethylene glycol 3350, 99.973% w/w INACTIVE INGREDIENTS: see section 6 in the leaflet – “ ADDITIONAL INFORMATION ”. PEGLAX ORANGE Powder for preparing an oral solution THE ACTIVE INGREDIENT AND ITS CONCENTRATION: Polyethylene glycol 3350, 99.365% w/w INACTIVE INGREDIENTS: see section 6 in the leaflet – “ ADDITIONAL INFORMATION ”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. Use the preparation according to the instructions in the dosage section of this leaflet. Consult the pharmacist if you need more information. Refer to the doctor if signs of the ailment (symptoms) worsen or do not improve. Peglax does not contain sugar and is therefore suitable for diabetics. 1. WHAT IS THE MEDICINE INTENDED FOR? The medicine is intended for treatment of constipation. Peglax softens the stool by increasing the stool water content, causes normal intestinal activity and thus relieves constipation. THERAPEUTIC CLASS: Osmotic laxative. 2. BEFORE USING THE MEDICINE DO NOT USE THIS MEDICINE IF: • You are sensitive (allergic) to the active ingredient (polyethylene glycol 3350) or to any of the other ingredients this medicine contains (for a list of inactive ingredients see section 6 in leaflet – “Additional information”). • You suffer from an intestinal or colon disease (such as ulcerative inflammation of the large intestine, Crohn’s disease). • You suffer from abdominal pain of undetermined cause. • You have or suspect you may have gastrointestinal perforation. • You have or suspect you may have bowel obstruction. SPECIAL WARNINGS REGARDING THE USE OF THE MEDICINE • The medicine contains polyethylene glyco Lugege kogu dokumenti